---
title: "RPL35A"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "## Gene Information"
tags: ['RPL35A', 'RibosomalProtein', 'DiamondBlackfanAnemia', 'AcuteMyeloidLeukemia', 'GeneticVariations', 'Treatment', 'Prognosis', 'DrugResponse']
---

## Gene Information

**Gene:** RPL35A (Ribosomal Protein L35a)

**Function:** Ribosomal Protein L35a is a component of the large subunit of the ribosome, which plays a critical role in protein synthesis.

**External IDs:** 

- HGNC: HGNC:10249
- NCBI Entrez: 6161
- Ensembl: ENSG00000188141
- OMIM: 603636
- UniProtKB/Swiss-Prot: P18077

**Aliases:** L35A, RPL35 

**Genomic Location:** Chromosome 3q29

## Genetic Variations

**AA mutation list and mutation type with dbSNP ID:**

No known AA mutation has been reported in the RPL35A gene yet in dbSNP database.

**Somatic SNVs/InDels with dbSNP ID:**

No somatic SNVs/InDels have been reported in the RPL35A gene yet in dbSNP database.

## Related Disease

Mutations in the RPL35A gene have been associated with the following diseases:

- Diamond-Blackfan anemia 4 (DBA4) 
- Acute myeloid leukemia (AML)

## Treatment and Prognosis

No specific treatment is available for RPL35A-related diseases yet. Treatment is generally symptomatic and supportive. The prognosis depends on the severity of the underlying condition and other factors.

## Drug Response

No known drug response information is available for RPL35A-related diseases.

## Related Papers
- Lee Han K. et al. "Risk of myeloid neoplasms after diamond-blackfan anemia" Haematologica. 2018;103(10):1667-1674. doi: 10.3324/haematol.2018.190926
- Mirabello L. et al. "Acquired Diamond-Blackfan Anemia: A New Presentation of Myelodysplastic Syndrome" Pediatr Blood Cancer. 2016;63(12):2166-2169. doi: 10.1002/pbc.26161

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**